Archive for March 2011

X-Hero and Male Enhancer: Recall – Undeclared Drug Ingredient

This is a reprint of the FDA alert. ISSUE: FDA lab analysis of X-Hero found the product contains sulfosildenafil, the analogue of the active ingredient of an FDA-approved drug used to treat erectile dysfunction (ED), making X-Hero an unapproved drug. In addition, FDA analysis of Male Enhancer sample found the product contains tadalafil, the active…

[...]

20 Tons of Fake Antibiotics, Analgesics and Other Medicines Collected in Peru

Peruvian officials have confiscated 20 tons of fake medication since 2007. 30% of the fakes confiscated were counterfeit antibiotics and another 30% fraudulent analgesics. Peru’s General Agency for Medicine and Drugs (Digemid) reported that antibiotics, analgesics and anti-inflammatories are the most fake medications in Peru, reported Living In Peru. “What is most often faked are…

[...]

Drug Dealers Moving into Counterfeit Medications in US Suburbs

In three separate suburban communities, people were arrested this week for possession of counterfeit drugs in the Washington, DC area and in Ohio suburbs. In Findlay, Ohio, Matthew Snodgrass, 23, faces charges of trafficking in drugs and counterfeit controlled substances, reports WFIN. Snodgrass is accused of selling ecstacy and a fake medication within 100 feet…

[...]

Medicine Cargo Drivers Vanished with Cargo in Russia

Two men, driving two separate cargo trucks of medication disappeared on March 13th in Russia, as did their trucks and the cargo within them, after crossing the Russian border from Finland. The two men, aged 60 and 25, disappeared on March 13. Subsequently, the two trucks they were driving were found without license plates, empty…

[...]

PSM Board Members Speak at 7th Annual San Diego Health Policy Conference, “Public-Private Partnerships in Global Health”

The reality that key issues in healthcare go beyond geo-
political lines is evident by challenges associated with important public
health concerns. Pandemics, human-sourced disasters, drug safety, HIV-
AIDS and TB control and treatment all represent global circumstances
that require a wide array of stakeholder efforts to effectively address.

Simultaneously, a much broader range of global health organizations have
increasingly played a role in addressing these and other international
public health needs beyond traditional public health authorities.
Foundations, international agencies outside the health realm, and the
private sector have also become key participants in creating policies and
programs in an effort to promote global public health.

Hence, the Institute of Health Law Studies (IHLS) convened the 7th Annual
San Diego Health Policy Conference
, entitled “Public-Private Partnerships
in Global Health.” The conference explored different models of public-
private partnerships emerging from the expansion of global health activities
to these larger bodies of groups, and will provide lessons for participants,
providers, and policymakers as to how to best engage these entities and
systems to most effectively and efficiently advance global health.

[...]

PSM Board Members Speak at 7th Annual San Diego Health Policy Conference, “Public-Private Partnerships in Global Health”

The reality that key issues in healthcare go beyond geo-
political lines is evident by challenges associated with important public
health concerns. Pandemics, human-sourced disasters, drug safety, HIV-
AIDS and TB control and treatment all represent global circumstances
that require a wide array of stakeholder efforts to effectively address.

Simultaneously, a much broader range of global health organizations have
increasingly played a role in addressing these and other international
public health needs beyond traditional public health authorities.
Foundations, international agencies outside the health realm, and the
private sector have also become key participants in creating policies and
programs in an effort to promote global public health.

Hence, the Institute of Health Law Studies (IHLS) convened the 7th Annual
San Diego Health Policy Conference
, entitled “Public-Private Partnerships
in Global Health.” The conference explored different models of public-
private partnerships emerging from the expansion of global health activities
to these larger bodies of groups, and will provide lessons for participants,
providers, and policymakers as to how to best engage these entities and
systems to most effectively and efficiently advance global health.

[...]

PSM Board Members Speak at 7th Annual San Diego Health Policy Conference, “Public-Private Partnerships in Global Health”

Tom Kubic speaking at another conferenceby Safe Medicines via Flickr. The reality that key issues in healthcare go beyond geo- political lines is evident by challenges associated with important public health concerns. Pandemics, human-sourced disasters, drug safety, HIV- AIDS and TB control and treatment all represent global circumstances that require a wide array of stakeholder…

[...]

Conference Speakers

Conference speakers, left to right: Scott LaGanga, Tom Kubic, Tom Novotny, Bryan Liang, Louise Gresham, Tim Mackey.

[...]

15 South Korean Pharmacists Indicted for Selling Fake Drugs

Investigators at the Seoul Central District Prosecutors Office have filed indictments against fifteen Seoul pharmacists for selling fake erectile dysfunction medications manufactured in China. Reports the Korea Herald, this is the first time pharmacists have been charged with selling fake medication in Seoul. Prosecutors say the pharmacists bought the medication from smugglers and then sold…

[...]

South America and Africa Employ Anti-Counterfeiting Technologies to Save Lives

Responding to the ongoing cases of counterfeiters in their countries, Argentinian and Nigerian pharmaceutical manufacturers are installing anti-counterfeiting solutions in their products. Gador Laboratories, located in Buenos Aires, is deploying a radio frequency identification (RFID) solution to track products and pallets, after a month-long pilot. The system has three levels of security with item-level RFID…

[...]